Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

TeleCareSpot vs Zealthy

TeleCareSpot
Graded #164

Higher grade

vs+21
Zealthy
Graded #496

Lower grade

The verdict

TeleCareSpot takes it — 67.7/100 to 46.7/100.

TeleCareSpot grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleCareSpot is a telehealth weight-loss platform offering doctor-prescribed compounded GLP-1s with flat, all-inclusive monthly pricing: compounded semaglutide at $299/month and tirzepatide at $399/month…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTeleCareSpot +17
43
26
Dose & formulationTeleCareSpot +19
83
64
Clinical oversightTeleCareSpot +42
83
41
Labs & monitoringZealthy +1
52
53
FulfillmentTeleCareSpot +26
92
66
Contract termsTeleCareSpot +20
61
41
TeleCareSpot · left barZealthy · right bar

The numbers

MetricTeleCareSpotZealthy
WeighScore67.7/10046.7/100
GradeCC
Scorecard rank#164#496
Semaglutide$299/mo (all doses, plus a separate fee, compounded)$286/mo (starting dose, plus a separate fee, compounded)
Tirzepatide$399/mo$351/mo (starting dose, plus a separate fee, compounded)
Coverage48 states34 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
TeleCareSpot

Graded #164 · C

Strengths

  • Flat, all-inclusive monthly pricing with no hidden fees — compounded semaglutide $299/month and tirzepatide $399/month, all doses included
  • Verifiable LegitScript certification (seal ID 45936855) plus HIPAA compliance and licensed US physicians
  • Multiple options: compounded semaglutide, tirzepatide, oral tirzepatide, and phentermine
  • DNA-calibrated dosing option that tailors the GLP-1 dose to how you metabolize it
  • Broad coverage in 47 states and DC, with free shipping and cancel-anytime plans

Where it loses points

  • Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Not available in Alaska, Mississippi, or New Jersey
  • The compounding pharmacy partner is not named
  • A separate weight-loss consultation fee applies (credited toward your medication package if approved)
  • Trustpilot rating and review counts (4.9, 14,000+) are self-stated on the site
Zealthy

Graded #496 · C

Strengths

  • Serves 34 states — meaningful nationwide footprint
  • Asynchronous model removes friction for patients who don't want a video visit
  • Independent licensed prescribers retain full clinical authority

Where it loses points

  • Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
  • Active DOJ/FTC enforcement alleging undisclosed subscription terms, locked cancellation, and unauthorized health-data sharing
  • Founder previously ran Cerebral, which settled with the FTC in 2024 over similar deceptive practices
  • Recently rebranded to Gronk Inc. amid active enforcement
  • FDA issued this company a warning letter dated 1 September 2025; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard